LV11173B - Substituted pyrroles - Google Patents

Substituted pyrroles Download PDF

Info

Publication number
LV11173B
LV11173B LVP-94-100A LV940100A LV11173B LV 11173 B LV11173 B LV 11173B LV 940100 A LV940100 A LV 940100A LV 11173 B LV11173 B LV 11173B
Authority
LV
Latvia
Prior art keywords
methyl
indol
dione
indolyl
pyrrole
Prior art date
Application number
LVP-94-100A
Other languages
English (en)
Latvian (lv)
Other versions
LV11173A (lv
Inventor
William Harris
Christopher Huw Hill
Geoffrey Lawton
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939309602A external-priority patent/GB9309602D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LV11173A publication Critical patent/LV11173A/xx
Publication of LV11173B publication Critical patent/LV11173B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
LVP-94-100A 1993-05-10 1994-05-09 Substituted pyrroles LV11173B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309602A GB9309602D0 (en) 1993-05-10 1993-05-10 Substituted pyrroles
GB9403249A GB9403249D0 (en) 1993-05-10 1994-02-21 Substituted pyrroles

Publications (2)

Publication Number Publication Date
LV11173A LV11173A (lv) 1996-04-20
LV11173B true LV11173B (en) 1996-06-20

Family

ID=26302877

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-100A LV11173B (en) 1993-05-10 1994-05-09 Substituted pyrroles

Country Status (25)

Country Link
EP (1) EP0624586B1 (de)
JP (1) JP2668818B2 (de)
CN (1) CN1048014C (de)
AT (1) ATE184007T1 (de)
AU (1) AU678435B2 (de)
BG (1) BG98761A (de)
BR (1) BR9401935A (de)
CA (1) CA2121567A1 (de)
CZ (1) CZ112894A3 (de)
DE (1) DE69420310T2 (de)
DK (1) DK0624586T3 (de)
ES (1) ES2137281T3 (de)
FI (1) FI106961B (de)
GR (1) GR3031901T3 (de)
HR (1) HRP940287B1 (de)
HU (1) HU215954B (de)
IL (1) IL109547A (de)
IS (1) IS1690B (de)
LT (1) LT3288B (de)
LV (1) LV11173B (de)
NO (1) NO301230B1 (de)
NZ (1) NZ260475A (de)
RU (1) RU2141960C1 (de)
SI (1) SI0624586T1 (de)
SK (1) SK53594A3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137203C (en) * 1993-12-07 2006-11-28 William Francis Heath Jr. Protein kinase c inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
DK0695755T3 (da) * 1994-08-04 1999-06-28 Hoffmann La Roche Pyrrolocarbazoler
IL126272A0 (en) * 1996-03-20 1999-05-09 Lilly Co Eli Synthesis of indolylmaleimides
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
ATE284885T1 (de) 2000-07-27 2005-01-15 Hoffmann La Roche 3-indolyl-4-phenyl-1h-pyrrol-2,5-dion derivate als glycogen synthase kinase 3beta inhibitoren
NZ532136A (en) 2001-10-30 2006-08-31 Novartis Ag Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
EP1653973A1 (de) 2003-08-08 2006-05-10 Novartis AG Kombinationen mit staurosporinen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
DE3833008A1 (de) * 1988-09-29 1990-04-05 Goedecke Ag Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles

Also Published As

Publication number Publication date
NZ260475A (en) 1996-02-27
RU2141960C1 (ru) 1999-11-27
LTIP1927A (en) 1994-11-25
FI942158A0 (fi) 1994-05-10
IL109547A0 (en) 1994-08-26
HU215954B (hu) 1999-03-29
LT3288B (en) 1995-06-26
IS1690B (is) 1998-04-20
GR3031901T3 (en) 2000-02-29
DE69420310T2 (de) 2000-04-13
CN1048014C (zh) 2000-01-05
HRP940287B1 (en) 2000-02-29
EP0624586B1 (de) 1999-09-01
IL109547A (en) 1998-07-15
SK53594A3 (en) 1995-02-08
JP2668818B2 (ja) 1997-10-27
EP0624586A1 (de) 1994-11-17
NO941682D0 (no) 1994-05-06
BR9401935A (pt) 1995-03-07
ES2137281T3 (es) 1999-12-16
HU9401298D0 (en) 1994-08-29
ATE184007T1 (de) 1999-09-15
NO301230B1 (no) 1997-09-29
LV11173A (lv) 1996-04-20
HRP940287A2 (en) 1996-12-31
DK0624586T3 (da) 2000-03-27
IS4162A (is) 1994-11-11
HUT71492A (en) 1995-11-28
FI942158A (fi) 1994-11-11
BG98761A (en) 1995-03-31
CN1103402A (zh) 1995-06-07
AU6055594A (en) 1994-11-17
JPH06329672A (ja) 1994-11-29
AU678435B2 (en) 1997-05-29
NO941682L (no) 1994-11-11
FI106961B (fi) 2001-05-15
CZ112894A3 (en) 1994-12-15
CA2121567A1 (en) 1994-11-11
DE69420310D1 (de) 1999-10-07
SI0624586T1 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
RU2075474C1 (ru) Замещенные пирролы, а также их фармацевтически приемлемые кислотноаддитивные соли, способ их получения и фармацевтическая композиция
EP0384349B1 (de) Substituierte Pyrrole
US5292747A (en) Substituted pyrroles
LV11173B (en) Substituted pyrroles
AU2003279230A1 (en) AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
JPS61112060A (ja) ピペラジン化合物
KR20210042935A (ko) Pad4 억제제로서의 치환된 티에노피롤
US5753657A (en) Imidazo 1,2-A! pyrazine-4-one, preparation thereof and drugs containing same
US5591739A (en) 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5688965A (en) Azabicyclic compounds useful as an intermediate for the preparation of pyidone carboxylic acid compounds and process for preparing the same
JP3162495B2 (ja) １，７−縮合環化された３−（ピペラジノアルキル）インドール誘導体、その製造のための方法および中間生成物並びに該化合物を含有する抗炎症性作用および抗アレルギー作用を有する医薬品
US5721230A (en) Substituted pyrroles
Boisbrun et al. A Convenient Synthesis of Indole‐Substituted 2‐Pyrrolidones and Their Cyclized Derivatives
HU198937B (en) Process for producing indolopyrazino benzodiazepine derivatives and pharmaceutical compositions comprising same
KR100331515B1 (ko) 치환된피롤
HU203889B (en) Process for producing heterocyclic lactame derivatives and pharmaceutical compositions containing them as active components
AU640202B2 (en) 2,4,8-trisubstituted-3h,6h-1,4,5a,8a-tetraazaacenaphthylene- 3,5-(4h)-diones
EP0145304B1 (de) Tetrahydro-beta-carbolinderivate und Verfahren zu ihrer Herstellung